Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129798) titled 'Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Chinese University of Hong Kong
Condition:
Macular Hole
Myopia
Intervention:
Procedure: ILM flap with no endotamponade technique
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 18, 2024
Target Sample Size: 20
Countries of Recruitment:
Hong Kong
To know more, visit https://clinicaltrials.gov/ct2/show...